NB3 fundamentals
An in-depth look to NEUROCRINE BIOSCIENCES INC operating, investing, and financing activities
NB3 free cash flow for Q1 24 is 110.38 M EUR. For 2023, NB3 free cash flow was 327.61 M EUR and operating cash flow was 353.25 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM